Regeneron Pharmaceuticals
United States
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
regeneron.com
David Simon
Senior Vice President, IOPS Finance and Business Operations
Company
Other leaders at Regeneron Pharmaceuticals
Alessandra Ravetti
Senior Vice President, Associate General Counsel Ā· Legal
Regeneron Pharmaceuticals Ā· United States
Andrew Deubler
Senior Vice President, Chief Business and Administrative Officer, Regeneron Genetics Center
Regeneron Pharmaceuticals Ā· United States
Andrew Murphy, PhD
Executive Vice President, Research Ā· Research & Development
Regeneron Pharmaceuticals Ā· United States
Arthur F. Ryan
Former Chief Executive Officer and Chair of the Board, Prudential Financial, Inc. Ā· Executive Management
Regeneron Pharmaceuticals Ā· United States
Bari Kowal
Senior Vice President, Development Operations, Portfolio Management & Biostatistics Data Management Ā· Digital
Regeneron Pharmaceuticals Ā· United States
Benjamin Drosman
Senior Vice President, Global Development Quality & Regulatory Compliance Ā· Compliance
Regeneron Pharmaceuticals Ā· United States
Benjamin Yocum
Senior Vice President, Manufacturing Operations Ā· Manufacturing
Regeneron Pharmaceuticals Ā· United States
Bob McCowan
Senior Vice President, IT and Chief Information Officer Ā· Information Technology
Regeneron Pharmaceuticals Ā· United States
Brian Zambrowicz, PhD
Executive Vice President, Functional Genomics and Chief VelociGeneĀ® Operations Ā· Operations
Regeneron Pharmaceuticals Ā· United States
